Back to today’s briefing

Story perspectives

Revolutionary Gene Therapy Offers Hope for Sickle Cell Patients

1/31/2025

45 4

Summary

NHS Introduces Exa-cel

The NHS in England is on the brink of transforming sickle cell disease treatment with Exa-cel, an innovative gene-editing therapy costing £1.65 million. This groundbreaking treatment will benefit around 50 patients each year, particularly those unable to undergo stem cell transplants, offering them hope for a healthier life and reduced hospital visits.

Summary

NHS Introduces Exa-cel

The NHS in England is on the brink of transforming sickle cell disease treatment with Exa-cel, an innovative gene-editing therapy costing £1.65 million. This groundbreaking treatment will benefit around 50 patients each year, particularly those unable to undergo stem cell transplants, offering them hope for a healthier life and reduced hospital visits.

1 of 2

NHS Introduces Exa-cel

The NHS in England is on the brink of transforming sickle cell disease treatment with Exa-cel, an innovative gene-editing therapy costing £1.65 million. This groundbreaking treatment will benefit around 50 patients each year, particularly those unable to undergo stem cell transplants, offering them hope for a healthier life and reduced hospital visits.

1 / 2